Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium
Pietro Quaglino(Department of Medical Sciences), C. Ram‐Wolff(European Organisation for Research and Treatment of Cancer), Stephen Morris(King's College London), Nicola Pimpinelli(University of Florence), José Antônio Sanches(Universidade de São Paulo), Alessandro Pileri(Azienda USL di Bologna), Stefanie Porkert(Peter MacCallum Cancer Centre), Meenal Kheterpal(Duke Medical Center), Madeleine Duvic(Cancer Clinic), H. Miles Prince(Peter MacCallum Cancer Centre), Maria Teresa Fierro(University of Turin), Concepción Postigo‐Llorente(Research Institute Hospital 12 de Octubre), Robert Knobler(Medical University of Vienna), Chiara Astrua, Tomomitsu Miyagaki(Peter MacCallum Cancer Centre), E.J. Kim(University of Pennsylvania), Pablo L. Ortiz‐Romero(Hospital Universitario 12 De Octubre), Pierluigi Porcu(Thomas Jefferson University), Teresa Estrach(Hospital Clínic de Barcelona), Milena Maule(University of Turin), Emmilia Hodak(Rabin Medical Center), Christopher McCormack(The University of Melbourne), Francesco Onida(Peter MacCallum Cancer Centre), Evangelia Papadavid(National and Kapodistrian University of Athens), Makoto Sugaya(International University of Health and Welfare), Paolo Fava, M. Bagot(Inserm), G. Ognibene(Columbia University Irving Medical Center), Simona Osella‐Abate, Maarten H. Vermeer(Leiden University Medical Center), Denis Miyashiro(Peter MacCallum Cancer Centre), Joan Guitart(Northwestern Memorial Hospital), Cristina Muniesa(Peter MacCallum Cancer Centre), Andrea Combalía(European Organisation for Research and Treatment of Cancer), Vieri Grandi(Peter MacCallum Cancer Centre), Stephanie K. Fabbro(The Ohio State University), Emilio Berti(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Silvia Alberti Violetti(University of Milan), Constanze Jonak, Octavio Servitje(Bellvitge University Hospital), Sarah McCue Horwitz(New York University), Pier Luigi Zinzani(Istituto di Ematologia di Bologna), C. Antoniou(National and Kapodistrian University of Athens), Iris Amitay‐Laish(Peter MacCallum Cancer Centre), R. Talpur(The University of Texas MD Anderson Cancer Center), Estela Martínez-Escala(Northwestern University), Fiona Child(European Organisation for Research and Treatment of Cancer), Rudolf Stadler(University Hospitals of the Ruhr-University of Bochum), Sridhar Chaganti(Cutaneous Lymphoma Foundation), Vasiliki Nikolaou(European Organisation for Research and Treatment of Cancer)
Cited by 136
Related Papers
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
|Journal of Clinical Oncology|2011|657
Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma
|Journal of Clinical Oncology|2001|610
Mental Health Service Use in the Community and Schools: Results from the Four-Community MECA Study
|Journal of the American Academy of Child & Adolescent Psychiatry|1996|609